CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and ...
Enabling Rapid and Reliable Diagnosis and Research of Rare Genetic Diseases Around the World CENTOGENE’s FilterTool aims to fuel rapid, reliable analysis for diagnosis and research of rare genetic ...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative ...